323 related articles for article (PubMed ID: 24531128)
1. Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinoma.
Han X; Li F; Fang Z; Gao Y; Li F; Fang R; Yao S; Sun Y; Li L; Zhang W; Ma H; Xiao Q; Ge G; Fang J; Wang H; Zhang L; Wong KK; Chen H; Hou Y; Ji H
Nat Commun; 2014; 5():3261. PubMed ID: 24531128
[TBL] [Abstract][Full Text] [Related]
2. YAP inhibits squamous transdifferentiation of Lkb1-deficient lung adenocarcinoma through ZEB2-dependent DNp63 repression.
Gao Y; Zhang W; Han X; Li F; Wang X; Wang R; Fang Z; Tong X; Yao S; Li F; Feng Y; Sun Y; Hou Y; Yang Z; Guan K; Chen H; Zhang L; Ji H
Nat Commun; 2014 Aug; 5():4629. PubMed ID: 25115923
[TBL] [Abstract][Full Text] [Related]
3. Evidence, Mechanism, and Clinical Relevance of the Transdifferentiation from Lung Adenocarcinoma to Squamous Cell Carcinoma.
Hou S; Zhou S; Qin Z; Yang L; Han X; Yao S; Ji H
Am J Pathol; 2017 May; 187(5):954-962. PubMed ID: 28284717
[TBL] [Abstract][Full Text] [Related]
4. LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling.
Gao Y; Xiao Q; Ma H; Li L; Liu J; Feng Y; Fang Z; Wu J; Han X; Zhang J; Sun Y; Wu G; Padera R; Chen H; Wong KK; Ge G; Ji H
Proc Natl Acad Sci U S A; 2010 Nov; 107(44):18892-7. PubMed ID: 20956321
[TBL] [Abstract][Full Text] [Related]
5. S100A7 promotes lung adenocarcinoma to squamous carcinoma transdifferentiation, and its expression is differentially regulated by the Hippo-YAP pathway in lung cancer cells.
Wang R; Li Y; Hu E; Kong F; Wang J; Liu J; Shao Q; Hao Y; He D; Xiao X
Oncotarget; 2017 Apr; 8(15):24804-24814. PubMed ID: 28177901
[TBL] [Abstract][Full Text] [Related]
6. YAP promotes malignant progression of Lkb1-deficient lung adenocarcinoma through downstream regulation of survivin.
Zhang W; Gao Y; Li F; Tong X; Ren Y; Han X; Yao S; Long F; Yang Z; Fan H; Zhang L; Ji H
Cancer Res; 2015 Nov; 75(21):4450-7. PubMed ID: 26363011
[TBL] [Abstract][Full Text] [Related]
7. Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2.
Zhang H; Fillmore Brainson C; Koyama S; Redig AJ; Chen T; Li S; Gupta M; Garcia-de-Alba C; Paschini M; Herter-Sprie GS; Lu G; Zhang X; Marsh BP; Tuminello SJ; Xu C; Chen Z; Wang X; Akbay EA; Zheng M; Palakurthi S; Sholl LM; Rustgi AK; Kwiatkowski DJ; Diehl JA; Bass AJ; Sharpless NE; Dranoff G; Hammerman PS; Ji H; Bardeesy N; Saur D; Watanabe H; Kim CF; Wong KK
Nat Commun; 2017 Apr; 8():14922. PubMed ID: 28387316
[TBL] [Abstract][Full Text] [Related]
8. Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.
Kim MJ; Shin HC; Shin KC; Ro JY
Ann Diagn Pathol; 2013 Feb; 17(1):85-90. PubMed ID: 23040737
[TBL] [Abstract][Full Text] [Related]
9. Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma.
Gout S; Brambilla E; Boudria A; Drissi R; Lantuejoul S; Gazzeri S; Eymin B
PLoS One; 2012; 7(10):e46539. PubMed ID: 23071587
[TBL] [Abstract][Full Text] [Related]
10. LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-small Cell Lung Cancer Plasticity and Therapeutic Response.
Li F; Han X; Li F; Wang R; Wang H; Gao Y; Wang X; Fang Z; Zhang W; Yao S; Tong X; Wang Y; Feng Y; Sun Y; Li Y; Wong KK; Zhai Q; Chen H; Ji H
Cancer Cell; 2015 May; 27(5):698-711. PubMed ID: 25936644
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress-triggered Wnt signaling perturbation characterizes the tipping point of lung adeno-to-squamous transdifferentiation.
Fang Z; Han X; Chen Y; Tong X; Xue Y; Yao S; Tang S; Pan Y; Sun Y; Wang X; Jin Y; Chen H; Hu L; Hui L; Li L; Chen L; Ji H
Signal Transduct Target Ther; 2023 Jan; 8(1):16. PubMed ID: 36627278
[TBL] [Abstract][Full Text] [Related]
12. Utility of WT-1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions.
Pu RT; Pang Y; Michael CW
Diagn Cytopathol; 2008 Jan; 36(1):20-5. PubMed ID: 18064689
[TBL] [Abstract][Full Text] [Related]
13. Expression of phosphatase and tensin homolog and programmed cell death ligand 1 in adenosquamous carcinoma of the lung.
Hlaing AM; Furusato B; Udo E; Kitamura Y; Souda M; Masutani M; Fukuoka J
Biochem Biophys Res Commun; 2018 Sep; 503(4):2764-2769. PubMed ID: 30100056
[TBL] [Abstract][Full Text] [Related]
14. Loss of transforming growth factor beta type II receptor increases aggressive tumor behavior and reduces survival in lung adenocarcinoma and squamous cell carcinoma.
Malkoski SP; Haeger SM; Cleaver TG; Rodriguez KJ; Li H; Lu SL; Feser WJ; Barón AE; Merrick D; Lighthall JG; Ijichi H; Franklin W; Wang XJ
Clin Cancer Res; 2012 Apr; 18(8):2173-83. PubMed ID: 22399565
[TBL] [Abstract][Full Text] [Related]
15. LKB1 Inactivation Promotes ROS-Induced Plasticity in NSCLC.
Cancer Discov; 2015 Jul; 5(7):OF22. PubMed ID: 25977220
[TBL] [Abstract][Full Text] [Related]
16. More expression of BDNF associates with lung squamous cell carcinoma and is critical to the proliferation and invasion of lung cancer cells.
Zhang SY; Hui LP; Li CY; Gao J; Cui ZS; Qiu XS
BMC Cancer; 2016 Feb; 16():171. PubMed ID: 26926340
[TBL] [Abstract][Full Text] [Related]
17. Heme Sequestration Effectively Suppresses the Development and Progression of Both Lung Adenocarcinoma and Squamous Cell Carcinoma.
Dey S; Ashrafi A; Vidal C; Jain N; Kalainayakan SP; Ghosh P; Alemi PS; Salamat N; Konduri PC; Kim JW; Zhang L
Mol Cancer Res; 2022 Jan; 20(1):139-149. PubMed ID: 34635508
[TBL] [Abstract][Full Text] [Related]
18. P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors.
Wang BY; Gil J; Kaufman D; Gan L; Kohtz DS; Burstein DE
Hum Pathol; 2002 Sep; 33(9):921-6. PubMed ID: 12378518
[TBL] [Abstract][Full Text] [Related]
19. Nintedanib selectively inhibits the activation and tumour-promoting effects of fibroblasts from lung adenocarcinoma patients.
Gabasa M; Ikemori R; Hilberg F; Reguart N; Alcaraz J
Br J Cancer; 2017 Oct; 117(8):1128-1138. PubMed ID: 28898237
[TBL] [Abstract][Full Text] [Related]
20. Identification of TRA2B-DNAH5 fusion as a novel oncogenic driver in human lung squamous cell carcinoma.
Li F; Fang Z; Zhang J; Li C; Liu H; Xia J; Zhu H; Guo C; Qin Z; Li F; Han X; Wang Y; Feng Y; Wang Y; Zhang W; Wang Z; Jin Y; Sun Y; Wei W; Zeng R; Chen H; Ji H
Cell Res; 2016 Oct; 26(10):1149-1164. PubMed ID: 27670699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
